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Abstract
Purpose: The aim of this study was to evaluate the extent of epicardial adipose tissue (EAT) and its relationship
with left ventricular (LV) parameters assessed by cardiovascular magnetic resonance (CMR) in patients with
congestive heart failure (CHF) and healthy controls.
Background: EAT is the true visceral fat deposited around the heart which generates various bioactive molecules.
Previous studies found that EAT is related to left ventricular mass (LVM) in healthy subjects. Further studies showed
a constant EAT to myocardial mass ratio in normal, ischemic and hypertrophied hearts.
Methods: CMR was performed in 66 patients with CHF due to ischemic cardiomyopathy (ICM), or dilated
cardiomyopathy (DCM) and 32 healthy controls. Ventricular volumes, dimensions and LV function were assessed.
The amount of EAT was determined volumetrically and expressed as mass indexed to body surface area.
Additionally, the EAT/LVM and the EAT/left ventricular remodelling index (LVRI) ratios were calculated.
Results: Patients with CHF had less indexed EAT mass than controls (22 ± 5 g/m2 versus 34 ± 4 g/m2, p < 0.0001). In
the subgroup analysis there were no significant differences in indexed EAT mass between patients with ICM and DCM
(21 ± 4 g/m2 versus 23 ± 6 g/m2, p = 0.14). Linear regression analysis showed that with increasing LV end-diastolic
diameter (LV-EDD) (r = 0.42, p = 0.0004) and LV end-diastolic mass (LV-EDM) (r = 0.59, p < 0.0001), there was a
significantly increased amount of EAT in patients with CHF. However, the ratio of EAT mass/LV-EDM was significantly
reduced in patients with CHF compared to healthy controls (0.54 ± 0.1 versus 0.21 ± 0.1, p < 0.0001). In CHF patients
higher indexed EAT/LVRI-ratios in CHF patients correlated best with a reduced LV-EF (r = 0.49, p < 0.0001).
Conclusion: Patients with CHF revealed significantly reduced amounts of EAT. An increase in LVM is significantly
related to an increase in EAT in both patients with CHF and controls. However, different from previous reports the
EAT/LVEDM-ratio in patients with CHF was significantly reduced compared to healthy controls. Furthermore, the LV
function correlated best with the indexed EAT/LVRI ratio in CHF patients. Metabolic abnormalities and/or anatomic
alterations due to disturbed cardiac function and geometry seem to play a key role and are a possible explanation
for these findings.
Background
Human epicardial adipose tissue (EAT) is the true visc-
eral fat of the heart whose regional distribution and
function is of growing scientific and clinical interest.
EAT covers 80% of the heart’s surface and constitutes
20% of total heart weight. It is located in the atrioventri-
cular and interventricular grooves, along the major
branches of the coronary arteries, around the atria, over
the free wall of the right ventricle and over the apex of
the left ventricle [1]. Cardiaovascular magnetic reso-
nance (CMR) using a volumetric approach has proven
to be a reproducible and feasible method to assess EAT
quantitatively [2].
Anatomically, there is a close relationship between the
EAT and the muscular components of the heart. In a
recent autopsy study, Corradi et al. [3] investigated the
relationship between the EAT and its underlying myo-
cardium in normal hearts and those who were ischemic,
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hypertrophic or both and found that a constant ratio of
fat to muscle exists in each ventricle. The presence of
myocardial ischemia and hypertrophy does not alter the
ratio of epicardial fat to cardiac muscle. In this context,
further echocardiographic findings by Iacobellis et al.
also demonstrated that an increase in epicardial fat is
significantly related to a consensual and proportional
increase in left ventricular mass in healthy subjects [4].
Being a metabolically active organ and a source of sev-
eral bioactive molecules [1,5,6] EAT may exert protec-
tive as well as unfavourable effects on the heart.
Growing evidence indicates that EAT might substan-
tially affect cardiovascular morphology and function. An
imbalance between the physiologic and pathologic roles
of EAT has been suggested in the development of car-
diac pathologies. However, little is known about the
changes of EAT coming along with the development of
heart failure and the concomitant deterioration of left
ventricular function.
Thus, the aim of this study was to assess the extent of
EAT and its relationship to the LV ejection fraction (EF%),
end-diastolic diameter (LV-EDD) and LV end-diastolic
mass (LV-EDM) assessed by cardiovascular magnetic reso-
nance (CMR) in patients with congestive heart failure




A total of 66 patients (54 males and 12 females; mean
age, 63± 2 years) consecutive patients with a history of
compensated symptomatic heart failure (NYHA func-
tional class II or greater) and the presence of cardiac
dysfunction on echocardiography study (left ventricular
function ≤ 35%) for more than one year were included in
the study. For the traditional binary classification
(ischemic vs. nonischemic), an ischemic aetiology of
heart failure was defined as the presence of any epicardial
coronary vessels with ≥75% stenosis or any history of
myocardial infarction or coronary revascularization. The
number-of-diseased-vessels classification was defined as
the number of vessels with ≥75% stenosis (0, 1, 2 or 3).
The diagnosis of dilated cardiomyopathy was based on
M-mode and 2D/Doppler echocardiographic examina-
tion demonstrating an end-diastolic diameter >56 mm
and a normal coronary angiography performed within
the previous 6 months.
The 32 healthy volunteers (25 males and 7 females, 57 ±
11 years) satisfied the following criteria: normal physical
examination, normal blood pressure (< 120 mm Hg and
<80 mm Hg), normal ECG findings, no history of chest pain
or dyspnea, no diabetes, and normal 2D echocardiographic
and Doppler examination. None of the subjects was on
medication. Any potential subjects with evidence of heart
disease, hypertension or other systemic disorders were
excluded from the study.
Image Acquisition
All studies were performed using a 1.5 Tesla whole-body
imaging system (Magnetom Sonata, Siemens Medical
Systems, Erlangen, Germany). A dedicated 4-element,
phased-array cardiac coil was used. Images were acquired
during repeated end-expiratory breath-holds. Scout
images (coronal, sagittal, and axial planes) were obtained
for planning of the final double-oblique long-axis and
short-axis views. To evaluate functional parameters, elec-
trocardiogram-gated cine images were then acquired
using a segmented steady-state free precession [fast ima-
ging with steady-state precession (true-FISP)] sequence
(time to echo/time of repetition 1.6/3.2 ms, temporal
resolution 35 ms, in-plane spatial resolution 1.4 1.8 mm,
slice thickness 5 mm, interslice gap 5 mm). Seven to 12
short-axis views covering the whole left and right ventri-
cle were obtained. For the assessment of the epicardial
adipose tissue, we used a dark blood prepared T1-
weighted multislice turbo spin-echo pulse sequence with
a water suppression prepulse to obtain a transversal
4-chamber view and short-axis images in the same orien-
tations used for the cine short-axis images. Imaging para-
meters were as follows: time of repetition = 800 ms, time
to echo = 24 ms, slice thickness = 4 mm, interslice gap =
2 mm, and field of view = 30 to 34 cm.
Ten minutes after injection of a gadolinium-based
contrast agent (Magnevist, Bayer-Schering Pharma AG,
Berlin, Germany), a segmented inversion recovery cine
trueFISP pulse sequence (TI scout) acquisition was per-
formed at a midventricular short-axis location. This
acquisition was used to determine the TI at which the
signal of normal myocardium is null for the subsequent
late gadolinium enhancement (LGE) acquisition. After
that, LGE images were acquired in the same orientation
as the cine images using a 2D-segmented inversion
recovery gradient-echo pulse sequence triggered to end-
diastole (repetition time/echo time = 9.6/4.4 ms, flip
angle 25°, matrix 208 × 256 and a typical voxel size of
1.6 × 1.3 × 5.0). LGE was only considered to be present
if it was also present in the same slice after swapping
phase encoding, thus excluding artifacts.
Image Analysis and Determination of Ventricular
Parameters
Image analysis and quantitative analysis was performed
off-line using dedicated software (ARGUS, Siemens).
Each study was examined for abnormalities in the mor-
phology of the right and left ventricle. End-diastolic and
end-systolic volumes and left ventricular mass was ana-
lyzed with the serial short-axis true-FISP cine loops,
using manual segmentation. Stroke volumes and ejection
Doesch et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:40
http://www.jcmr-online.com/content/12/1/40
Page 2 of 9
fractions were calculated. Additionally, left- and right-
ventricular diameters were measured.
Volumetric Assessment of the Absolute Mass of EAT
The amount of EAT was calculated by using the modified
Simpson’s rule with integration over the image slices. The
contours of EAT were outlined at end diastole in
the short-axis views covering the entire left and right ven-
tricle. For EAT mass determination, the area subtended by
the manual tracings was determined in each slice and mul-
tiplied by the slice thickness to yield the fat volume. Total
EAT volume was obtained after the data summation of all
slices. To obtain EAT mass, the volume of EAT was multi-
plied by the specific weight of fat (0.92 g/cm3). The obser-
ver was blinded to patient details.
Additionally, the left ventricular remodelling index
(LVRI) was calculated as the ratio of left ventricular
mass (LV-EDM) to left ventricular volume (LV-EDV) as
previously published by De Castro S et al. [7] who
established a LVRI of 1.03 ± 0.12 g/ml as normal value
in 152 healthy volunteers.
To assess inter- and intraobserver reproducibility of
the volumetric EAT measurements, two blinded investi-
gators evaluated 40 randomly selected subjects among
the study population and one of them repeated the mea-
surements two weeks after the first evaluation.
Late Gadolinium Enhancement
LGE was assessed visually, and the LGE mass was mea-
sured by manual planimetry on all short-axis slices by
an observer blinded to all patient details. Summing the
LGE mass of all slices yielded the total mass of LGE.
The extent of LGE was then expressed as a percentage
of the total LV mass.
Statistical Analysis
The data are presented as mean value SD. Body mass
index (BMI) was calculated by the common formula:
BMI (kg/m2) = weight (kg)/height (m)2. Body surface
area (BSA) was assessed by a variation of the DuBois
and DuBois formula: BSA (m2) = [weight (kg)0.425 ×
height (cm)0.725] × 0.007184 [8]. An unpaired, 2-tailed
student’s t-test was used for parametric data. The
Mann-Whitney U test, [chi]2 test was applied for non-
parametric data. A p-value <0.05 was considered signifi-
cant for all comparisons. Linear regression analysis was
performed on anthropometric and CMR parameters to
identify correlates of EAT. Multivariate analysis was per-
formed with logistic regression analysis using block
entry of the following variables: LV-EF (%), RV-EF(%),
LV-EDD (mm) and indexed LV-EDM (g/m2) to evaluate
if these variables were independent predictors of
indexed EAT mass. Besides, univariate linear regression
analysis was performed between LV-EF and indexed
EAT in CHF patients and healthy controls separately.
Furthermore, univariate linear regression analysis was
applied to determine the correlation between LV-EF and
left ventricular remodelling index (LVRI) calculated as
the ratio of left ventricular mass (LV-EDM) to left ven-
tricular volume (LV-EDV) as well as the indexed EAT/
LVRI-ratio in patients with CHF. Additionally, the LV-
EDM and the indexed EAT was compared in CHF
patients with and without hypertensive heart disease.
Analysis was performed using SPSS statistical software
(version 14.0, SPSS Inc., Chicago, Illinois).
Power calculation (two-sided paired t-test performed
with SAS, version 8.2 software [SAS Institute, Cary, NC]
to assess the sample size needed in this study was done
on the basis of the estimated standard deviation (SD)
between the indexed EAT of healthy controls and CHF
patients derived from the results of our previous study
[2]. According to this calculation, the number of sub-
jects needed to establish a power of 90% (with a = 0.05)
was 22 CHF patients and 11 healthy controls.
The inter- and intraobserver reproducibility was
assessed by Bland-Altman analysis, providing the mean
difference (d) and its limits of agreement (d ± 1.96 ×
SD, where SD = standard deviation of the differences).
Results
Demographics and Baseline characteristics
The baseline characteristics of all subjects studied are
shown in Table 1. There were no significant differences
regarding age, BMI and BSA between patients with
heart failure and controls.
Comparing the baseline characteristics of patients with
ICM and DCM (Table 2) it becomes evident that due to
the different disease course patients with ICM were
older and had a reduced body weight and BMI com-
pared to patients with DCM.
In our study cohort 21/66 (31.8%) patients suffered
from diabetes mellitus and were treated with oral anti-
diabetic medication 15/66 (22.7%) or insulin 6/66
(9.1%). 17/66 (36%) suffered from hypertensive heart
disease. Hyperlipidemia was diagnosed in 38/66 (57.6%).
Table 1 Demographics and baseline characteristics:






Age 57 ± 11 63 ± 12 0.06
Male Sex 25/32 (78%) 54/66 (82%) 0.44
Body weight (kg) 83 ± 14 80 ± 16 0.35
BSA (m2) 1.7 ± 0.1 1.9 ± 0.2 0.27
BMI (kg/m2) 28 ± 4 27 ± 4 0.49
Data are presented as the mean value ± SD.
BMI: body mass index, BSA: body surface area, CHF: chronic heart failure
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24/66 (36.4%) were smoker and 15/66 (22.7%) had a
family history of CAD.
Among the patients with ICM 34/36 (94%) suffered an
acute myocardial infarction 11.6 ± 7.3 years ago. None
of the DCM patients had a history of prior myocardial
infarction.
The severity of symptoms at admission was assessed
by NYHA classification. None of the patients were in
NYHA class I, 7/66 (11%) patients in II, and 59/66
(89%) patients in III-IV.
CMR parameters
The CMR characteristics of our study cohort are sum-
marized in Table 3. The mean extent of LGE in our
patients with ICM was 32.6 ± 10.4%.
In patients with CHF, left ventricular ejection fraction
(LV-EF) and right ventricular ejection fraction (RV-EF)
were significantly reduced whereas left ventricular end-
diastolic diameter (LV-EDD) and right ventricular end-
diastolic diameter (RV-EDD) as well as indexed left ven-
tricular end-diastolic mass (LV-EDM) were significantly
elevated compared to controls. Indexed EAT mass in
patients with heart failure was significantly lower com-
pared to controls as illustrated in Figure 1. Subgroup
analyis of CMR parameters in patients with ICM and
DCM (Table 4) revealed a comparably diminished LV-
EF and RV-EF. LV-EDD and RV-EDD were equally
increased and indexed LV-EDM as well as indexed EAT
mass were also comparable among patients with ICM
and DCM.
The intra- and interobserver correlation of EAT deter-
mination was good. The corresponding Bland-Altmann
plots for the intraobserver and interobserver variability
showed a mean value of 0.69% vs 3.18%, a SD of ± 0.96%
vs ± 3.13% and limits of agreement from -1.1% to +2.5%
vs -3.0% to +9.3% (intraobserver vs interobserver variabil-
ity respectively).
Correlation of indexed EAT mass with anthropometric
and CMR parameters
In patients with CHF simple linear regression analysis
revealed a significant correlation of indexed EAT mass
with LV-EF (r = 0.32, p = 0.008), LV-EDD (r = 0.42,
p = 0.0004), indexed LV-EDM (r = 0.59, p < 0.0001) and
RV-EF (r = 0.32, p = 0.009). This correlation was also exis-
tent in subgroup analysis in patients with DCM and ICM.
In patients with ICM there was no significant correlation
between indexed EAT and the LGE extent (%) (r = 0.11,
p = 0.52). No correlation was found between indexed EAT
mass and RV-EDD (r = 0.07, p = 0.6) as well as the
anthropometric parameters age (r = 0.04, p = 0.76) and
BMI (r = 0.06, p = 0.63). In healthy controls indexed EAT
mass only correlated with indexed LV-EDM (r = 0.36,
p = 0.04). Multivariate logistic regression analysis, a model
using the LV-EF, LV-EDD, indexed LV-EDM and RV-EF
to predict the extent of EAT in patients with CHF, showed
that indexed LV-EDM was the only parameter that was
independently associated with the indexed EAT mass
(p = 0.0001).
EAT mass/LV-EDM ratio
As illustrated on Figure 2A there is a parallel and corre-
lated increase in indexed EAT mass and indexed LV-EDM
in patients with CHF as well as in healthy controls. How-
ever, if compared to patients with CHF, healthy controls
showed a consistently higher EAT mass/LV-EDM ratio
Table 2 Demographics and baseline characteristics:






Age 66 ± 9 58 ± 14 0.01
Male Sex 31/36 (86%) 23/30 (77%) 0.36
Body weight (kg) 76 ± 13 85 ± 18 0.02
BSA (m2) 1.9 ± 0.2 2.0 ± 0.3 0.06
BMI (kg/m2) 26 ± 4 28 ± 5 0.02
NYHA functional class
I 0 0 -
II 2/36 5/30 0.99
III/IVI 34/36 25/30 0.56
Data are presented as the mean value ± SD. BSA: body surface area, BMI:
body mass index, CHF: chronic heart failure, DCM: dilated cardiomyopathy,
ICM: ischemic cardiomyopathy, NYHA: New York Heart Association
Table 3 CMR Characteristics: Healthy Controls and






LV-EF (%) 58 ± 5 27 ± 9 < 0.0001
LV-EDM (g) 125 ± 35 207 ± 56 < 0.0001
Indexed LV-EDM (g/m2) 64 ± 15 109 ± 28 < 0.0001
LV-ESV (ml) 75 ± 85 211 ± 76 < 0.0001
LV-EDV (ml) 141 ± 36 294 ± 86 < 0.0001
LV-EDD (mm) 50 ± 5 69 ± 8 < 0.0001
LVRI g/ml 0.9 ± 0.2 0.7 ± 0.2 0.001
RV-EF (%) 58 ± 6 42 ± 14 < 0.0001
RV-ESV (ml) 55 ± 16 103 ± 64 0.0001
RV-EDV (ml) 137 ± 32 168 ± 68 0.02
EAT volume (ml) 71 ± 13 46 ± 11 < 0.0001
Indexed EAT volume (ml/m2) 36 ± 5 24 ± 5 < 0.0001
EAT mass (g) 67 ± 13 43 ± 11 < 0.0001
Indexed EAT mass (g/m2) 34 ± 4 22 ± 5 < 0.0001
EAT mass/LV-EDM ratio 0.54 ± 0.1 0.21 ± 0.1 < 0.0001
Data are presented as the mean value ± SD.
CMR: cardiovascular magnetic resonance, EAT: epicardial adipose tissue, LV-
EDD: left ventricular end-diastolic diameter, LV-EDM: left ventricular end-
diastolic mass, LV-EDV: left ventricular end-diastolic volume, LV-EF: left
ventricular ejection fraction, LV-ESV: left ventricular end-systolic volume, RV-
EDV: right ventricular end-diastolic volume, RV-EF: right ventricular ejection
fraction, RV-ESV: right ventricular end-systolic volume
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Figure 1 Difference in EAT mass in healthy controls and patients with CHF. Volumetric measurement of EAT outlining the contours of EAT
in end-diastolic images of short axis covering the left and right ventricle in a healthy control with normal EAT mass (Panel A) and in a CHF
patient with reduced EAT mass (Panel B). CHF: chronic heart failure, EAT: Epicardial adipose tissue, LV-EDM: left ventricular enddiastolic mass
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(0.54 ± 0.1 versus 0.21 ± 0.1, p < 0.0001) that was also
illustrated by a higher intercept of the regression curve.
Among patients with DCM and ICM the EAT mass/
LV-EDM ratio (0.21 ± 0.1 versus 0.21 ± 0.1, p = 0.58) was
similar (Figure 2B). Comparing the LV-EDM (222.9 ± 86.1
g versus 201.9 ± 40.0, p = 0.18) and indexed EAT (22.4 ±
5.3 g/m2 versus 22.2 ± 4.8 g/m2, p = 0.87) results between
CHF patients with and without hypertensive heart disease
there was no significant difference.
Correlation between LV-EF and LGE, indexed EAT as well
as parameters of left ventricular remodelling
In CHF patients a reduced LV-EF correlated inversely
with the LGE extent % (r = 0.41, p = 0.01). Looking at
the correlation between LV-EF and indexed EAT as well
as parameters of left ventricular remodelling, there was
no significant correlation between LV-EF and indexed
EAT in healthy controls (r = 0.09, p = 0.64, Figure 3A).
Whereas in CHF patients, we found an inversed correla-
tion between LV-EF and indexed EAT (r = 0.31,
p = 0.01, Figure 3B). In contrast to healthy controls who
exhibited a normal LVRI, CHF patients had a signifi-
cantly reduced LVRI (0.9 ± 0.2 g/ml vs 0.7 ± 0.2 g/ml,
p = 0.001). In CHF patients, the reduced LV-EF was
positively correlated with a decreased LVRI (r = 0.32,
p = 0.01, Figure 3C). Irrespective of the aetiology of
heart failure, higher indexed EAT/LVRI-ratios in CHF
patients correlated best with a reduced LV-EF (r = 0.49,
p < 0.0001, Figure 3D).
Discussion
Our study demonstrates that in patients with CHF and
severely reduced impaired LV-EF (LV-EF < 35%), EAT
is significantly reduced compared to healthy controls.
The reduction of EAT is irrespective of the underlying
aetiology of the cardiomyopathy. Like in healthy con-
trols an increase in left ventricular mass also leads to an
augmentation of the EAT mass in patients with CHF,
however, the EAT mass/LV-EDM ratio is significantly
lower compared to healthy controls.
The amount of EAT has been assessed by numerous
imaging modalities [2,4,9,10]. Fluechter et al. [2] were
the first to describe a volumetric measurement of epi-
cardial fat volume using CMR. This method turned out
to be less influenced by the individual cardiac anatomy
and fat distribution compared to echocardiographic
measurements at single points and was used for the
assessment of EAT in our study.
So far, the role of EAT and its contribution to the devel-
opment of cardiac pathology is quite ambiguous. There is
growing evidence of a close functional and anatomical
relationship between the adipose tissue and muscular
components of the heart. Its close proximity to the myo-
cardium suggests that EAT as a metabolically active organ
and a source of several bioactive molecules may influence
cardiac morphology and function [1,11,12]. Under physio-
logical conditions EAT is supposed to act as a buffering
system between the myocardium and the local vascular
bed [13,14]. Increased EAT could serve as a scavenger of
excess fatty free acids which interfere with the generation
and propagation of the contractile circle of the heart, may
cause ventricular arrhythmias and are supposed to alter
cardiac repolarization [15,16]. On the other hand, EAT
possesses a high lipolytic activity so that it is able to serve
as a ready source of free fatty acids under conditions of an
increased myocardial energy demand [1].
Our results showed that patients with CHF had less
indexed EAT mass than controls. In the subgroup analysis
there were no significant differences in indexed EAT mass
between patients with ICM and DCM. In healthy controls
there was no significant correlation between indexed EAT
and LV-EF. In contrast, CHF patients revealed a significant
inversed correlation between indexed EAT and LV-EF as
well as RV-EF and a linear correlation between indexed
EAT and LV-EDD. However, indexed EAT did not corre-
late with RV-EDD, which was due to the predominantly
left ventricular heart failure. Compared to healthy controls
who possessed a normal left ventricular remodelling index
(LVRI), CHF patients had a significantly reduced LVRI. In
CHF patients, the reduced LV-EF showed a positive corre-
lation with the decreased LVRI. As indicated by a signifi-
cant interaction between indexed EAT and left ventricular
remodelling, higher indexed EAT/LVRI-ratios in CHF
Table 4 CMR Characteristics: Subgroup Analysis






LV-EF (%) 27 ± 9 26 ± 8 0.75
LV-EDM (g) 194 ± 45 223 ± 64 0.03
Indexed LV-EDM (g/m2) 104 ± 23 115 ± 32 0.12
LV-ESV (ml) 211 ± 76 227 ± 89 0.42
LV-EDV (ml) 283 ± 73 308 ± 99 0.25
LV-EDD (mm) 68 ± 7 70 ± 9 0.32
RV-EF (%) 44 ± 15 40 ± 13 0.28
RV-ESV (ml) 92 ± 46 117 ± 79 0.10
RV-EDV (ml) 155 ± 47 183 ± 55 0.10
EAT volume (ml) 43 ± 10 49 ± 13 0.03
Indexed EAT volume (ml/m2) 23 ± 5 25 ± 6 0.14
EAT mass (g) 40 ± 9 46 ± 12 0.03
Indexed EAT mass (g/m2) 21 ± 4 23 ± 6 0.14
EAT mass/LV-EDM ratio 0.21 ± 0.1 0.21 ± 0.1 0.58
CMR: cardiac magnetic resonance, EAT: epicardial adipose tissue, LV-EF: left
ventricular ejection fraction, LV-EDD: left ventricular end-diastolic diameter,
LV-EDM: left ventricular end-diastolic mass, LV-EDV: left ventricular end-
diastolic volume, LV-ESV: left ventricular end-systolic volume, RV-EDV: right
ventricular end-diastolic volume, RV-EF: right ventricular ejection fraction, RV-
ESV: right ventricular end-systolic volume
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patients correlated best with a reduced LV-EF. This corre-
lation existed regardless of the underlying aetiology of
heart failure. The reversal of the correlation between LV-
EF and indexed EAT seen in our CHF patients can be
explained by the modification in left ventricular shape and
size coming along with left ventricular remodelling due to
progressive heart failure. Since changes in left ventricular
geometry are dynamic, affecting both mass and volume,
the LVRI is significantly reduced in CHF patients. With
decreasing LV-EF, CHF patients showed an decrease in
LVRI and indexed EAT increase resulting in an increasing
indexed-EAT-LVRI ratio, indicating a remodelling not
compensated by an adequate EAT increase.
The extent of LGE in our 36 ICM patients was 32.6 ±
10.4%. As anticipated there was a significant correlation
between the LV-EF and the LGE extent, whereas no sig-
nificant correlation existed between indexed EAT and
the LGE extent. However, due to the small number of
patients in the subgroup analysis, our study might be
underpowered for this analysis.
Previous studies [3,17] showed a close relationship
between ventricular muscle mass and EAT. This
Figure 2 Regression Plot of indexed EAT mass vs indexed LV-EDM. Panel A illustrates the significant correlation of indexed EAT mass and
indexed LV-EDM in patients with CHF and in healthy controls. Panel B shows the subgroup analysis of the relationship between indexed EAT
mass and indexed LV-EDM in patients with DCM and patients with ICM. CHF: chronic heart failure, DCM: dilated cardiomyopathy, EAT: Epicardial
adipose tissue, ICM: ischemic cardiomyopathy, LV-EDM: left ventricular end-diastolic mass.
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hypothesis of a tight relationship between muscle and fat
mass is also corroborated by anatomical observations [18].
Corradi D et al. [3] described a constant fat-muscle ratio in
each ventricle which is not influenced by ischemia or
hypertrophy. Our study also observed a constant and par-
allel increase of left ventricular mass and EAT in patients
with severe heart failure. However, the fat-muscle ratio is
significantly lower in patients with severe heart failure
compared to healthy controls with preserved left ventricu-
lar function. These results are in line with a post-mortem
study by Schejbal V. et al. [18] who also found significantly
less EAT in patients with signs of congestive heart failure.
Additionally, in the study by Corradi et al. [3] patients with
hypertrophy had a left ventricular mass of 226 ± 67 g and a
EAT of 73 ± 23 g, the ischemic hypertrophic patients dis-
played a left ventricular mass of 225 ± 59 g and a EAT of
76 ± 32 g. Our CHF patients had a comparable left ventri-
cular mass 207 ± 56 g however, the EAT was significantly
reduced 43 ± 11 g. Therefore, we assume that the reduced
ratio is not caused by excessive LV hypertrophy but is the
effect of an insufficient EAT increase in the failing heart.
Comparing the LV-EDM and EAT results between CHF
patients with and without hypertensive heart disease there
was no significant difference.
In patients with CHF and a severely reduced LV-EF, the
reduced EATmass/left ventricular mass ratio may indicate
a decreased buffering capacity for excess fatty free acids as
well as a diminished responsiveness to adjust to special
energy demands of the heart. A reduction of EAT may
result in a reduced adiponectin production that has shown
to exert protective effects under ischemic conditions [19].
Limitations
One limitation of our study is the relatively small num-
ber of study participants. Larger randomized trials
including patients with various degrees of left ventricu-
lar function impairment are needed to generalize our
observations and to prove whether they are linearly
related to LV-EF decrease.
Due to the different disease course and time of manifes-
tation patients with dilated cardiomyopathy were younger
than those with ischemic cardiomyopathy. However, as
the thickness of EAT does not change between the age of
40 and death [18] this fact should not alter the results of
our study.
We found a correlation between EAT and several MRI
parameters indicating left ventricular remodeling. How-
ever, as correlation is a necessary but not a sufficient
Figure 3 Correlation between LV-EF and indexed EAT, LVRI as well as the indexed EAT/LVRI ratio. Panel A shows the correlation
between LV-EF and indexed EAT in healthy controls. Panel B illustrates the correlation between LV-EF and indexed EAT in CHF patients. Panel
C displays the correlation between LV-EF and LVRI in CHF patients. The correlation between LV-EF and the indexed EAT/LVRI ratio is presented
on Panel D. CHF: chronic heart failure, EAT: epicardial adipose tissue, LV-EF: left ventricular function, LVRI: left ventricular remodelling index
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condition to make causal inference with reasonable confi-
dence, our study was not targeted on causal relationships
among these parameters and EAT and no conclusion on
the causality of the parameters can be drawn. It will be
the challenge of further studies to evaluate the potential
causal explanations of the observed correlations.
Conclusion
Patients with CHF revealed significantly reduced
amounts of EAT compared to healthy controls irrespec-
tive of the underlying aetiology of the cardiomyopathy.
An increase in LVM is significantly related to an increase
in EAT in both patients with CHF and controls. How-
ever, different from previous reports the EAT/LVEDM-
ratio in patients with CHF was significantly reduced com-
pared to healthy controls. Metabolic abnormalities and/
or anatomic alterations due to disturbed cardiac function
and geometry seem to play a key role and are a possible
explanation for these findings. Furthermore, as indicated
by a significant interaction between indexed EAT and left
ventricular remodelling, higher indexed EAT/LVRI-ratios
in CHF patients correlated best with a reduced LV-EF.
Abbreviations
CHF: congestive heart failure; CMR: cardiovascular magnetic resonance; DCM:
dilated cardiomyopathy; EAT: epicardial adipose tissue; ICM: ischemic
cardiomyopathy; LA: left atrium; LGE: late gadolinium enhancement; LV: left
ventricle.
Author details
11st Department of Medicine, University Medical Centre Mannheim, Medical
Faculty Mannheim, University of Heidelberg, Germany. 2Department of
Clinical Radiology and Nuclear Medicine, University Medical Center
Mannheim, Medical Faculty Mannheim, University of Heidelberg, Germany.
Authors’ contributions
CD evaluated CMR images, participated in study-design, performed statistical
analysis and drafted the manuscript, figures and tables. DH contributed
equally to the writing of this manuscript. SF participated in study-design and
evaluation of CMR data. TS participated in study-design and the revision of
the manuscript. SS participated in study-design and evaluation of CMR-
images. HM participated in the revision of the manuscript and repeated the
EAT volumetry to assess interobserver measurement reproducibility. MB
participated in study-design, scientific and clinical advice concerning CHF
and was responsible for the revision of the manuscript. TP participated in
study-design and its coordination, performed and evaluated CMR images
and was responsible for the revision of the manuscript. All authors read and
approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 20 December 2009 Accepted: 12 July 2010
Published: 12 July 2010
References
1. Iacobellis G, Corradi D, Sharma AM: Epicardial adipose tissue: anatomic,
biomolecular and clinical relationships with the heart. Nat Clin Pract
Cardiovasc Med 2005, 2:536-543.
2. Fluchter S, Haghi D, Dinter D, Heberlein W, Kuhl HP, Neff W, Sueselbeck T,
Borggrefe M, Papavassiliu T: Volumetric assessment of epicardial adipose
tissue with cardiovascular magnetic resonance imaging. Obesity (Silver
Spring) 2007, 15:870-878.
3. Corradi D, Maestri R, Callegari S, Pastori P, Goldoni M, Luong TV, Bordi C:
The ventricular epicardial fat is related to the myocardial mass in
normal, ischemic and hypertrophic hearts. Cardiovasc Pathol 2004,
13:313-316.
4. Iacobellis G, Ribaudo MC, Assael F, Vecci E, Tiberti C, Zappaterreno A, Di
Mario U, Leonetti F: Echocardiographic epicardial adipose tissue is
related to anthropometric and clinical parameters of metabolic
syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab
2003, 88:5163-5168.
5. Fantuzzi G, Mazzone T: Adipose tissue and atherosclerosis: exploring the
connection. Arterioscler Thromb Vasc Biol 2007, 27:996-1003.
6. Kankaanpaa M, Lehto HR, Parkka JP, Komu M, Viljanen A, Ferrannini E,
Knuuti J, Nuutila P, Parkkola R, Iozzo P: Myocardial triglyceride content
and epicardial fat mass in human obesity: relationship to left ventricular
function and serum free fatty acid levels. J Clin Endocrinol Metab 2006,
91:4689-4695.
7. De Castro S, Caselli S, Maron M, Pelliccia A, Cavarretta E, Maddukuri P,
Cartoni D, Di Angelantonio E, Kuvin JT, Patel AR, Pandian NG: Left
ventricular remodelling index (LVRI) in various pathophysiological
conditions: a real-time three-dimensional echocardiographic study. Heart
2007, 93:205-209.
8. Bland JM, Altman DG: Statistical methods for assessing agreement
between two methods of clinical measurement. Lancet 1986, 1:307-310.
9. Iacobellis G, Assael F, Ribaudo MC, Zappaterreno A, Alessi G, Di Mario U,
Leonetti F: Epicardial fat from echocardiography: a new method for
visceral adipose tissue prediction. Obes Res 2003, 11:304-310.
10. Taguchi R, Takasu J, Itani Y, Yamamoto R, Yokoyama K, Watanabe S,
Masuda Y: Pericardial fat accumulation in men as a risk factor for
coronary artery disease. Atherosclerosis 2001, 157:203-209.
11. Iacobellis G, Pistilli D, Gucciardo M, Leonetti F, Miraldi F, Brancaccio G,
Gallo P, di Gioia CR: Adiponectin expression in human epicardial adipose
tissue in vivo is lower in patients with coronary artery disease. Cytokine
2005, 29:251-255.
12. Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H, Sarov-
Blat L, O’Brien S, Keiper EA, Johnson AG, Martin J, Goldstein BJ, Shi Y:
Human epicardial adipose tissue is a source of inflammatory mediators.
Circulation 2003, 108:2460-2466.
13. Marchington JM, Mattacks CA, Pond CM: Adipose tissue in the
mammalian heart and pericardium: structure, foetal development and
biochemical properties. Comp Biochem Physiol B 1989, 94:225-232.
14. Marchington JM, Pond CM: Site-specific properties of pericardial and
epicardial adipose tissue: the effects of insulin and high-fat feeding on
lipogenesis and the incorporation of fatty acids in vitro. Int J Obes 1990,
14:1013-1022.
15. Manzella D, Grella R, Marfella R, Giugliano D, Paolisso G: Elevated post-
prandial free fatty acids are associated with cardiac sympathetic
overactivity in Type II diabetic patients. Diabetologia 2002, 45:1737-1738.
16. Paolisso G, Gualdiero P, Manzella D, Rizzo MR, Tagliamonte MR,
Gambardella A, Verza M, Gentile S, Varricchio M, D’Onofrio F: Association of
fasting plasma free fatty acid concentration and frequency of ventricular
premature complexes in nonischemic non-insulin-dependent diabetic
patients. Am J Cardiol 1997, 80:932-937.
17. Iacobellis G, Ribaudo MC, Zappaterreno A, Iannucci CV, Leonetti F: Relation
between epicardial adipose tissue and left ventricular mass. Am J Cardiol
2004, 94:1084-1087.
18. Schejbal V: [Epicardial fatty tissue of the right ventricle–morphology,
morphometry and functional significance]. Pneumologie 1989, 43:490-499.
19. Shibata R, Sato K, Pimentel DR, Takemura Y, Kihara S, Ohashi K, Funahashi T,
Ouchi N, Walsh K: Adiponectin protects against myocardial ischemia-
reperfusion injury through AMPK- and COX-2-dependent mechanisms.
Nat Med 2005, 11:1096-1103.
doi:10.1186/1532-429X-12-40
Cite this article as: Doesch et al.: Epicardial adipose tissue in patients
with heart failure. Journal of Cardiovascular Magnetic Resonance 2010
12:40.
Doesch et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:40
http://www.jcmr-online.com/content/12/1/40
Page 9 of 9
